logo

For the Inventor, By the Inventor

Union City, CA, United States of America

Abaxis, Inc.


USPTO Granted Patents = 60

% Expired Patents = 1.7



Trademarks = 10

Forward Citations = 1,897

Loading Chart...
Loading Chart...

39 inventors (with patents filed for the assignee):

goldMedal Rajesh K Mehra (32 out of 46 patents)

silverMedal Kenneth P Aron (32 out of 52 patents)

bronzeMedal Dennis M Bleile (22 out of 27 patents)

4.  Jeremy D Walker (17 out of 22 patents)

5.  Cristina R Cuesico (15 out of 20 patents)

6.  Carol T Schembri (13 out of 71 patents)

7.  Timothy Patrick Forsyth (9 out of 30 patents)

8.  Tammy L Burd (9 out of 9 patents)

9.  Steven N Buhl (8 out of 8 patents)

10.  Vincent Chiang (7 out of 12 patents)

11.  Thuy N Tang (6 out of 6 patents)

12.  Chi-Sou Yu (6 out of 6 patents)

13.  Bhaskar Bhayani (6 out of 6 patents)

14.  Vladimir E Ostoich (5 out of 5 patents)

15.  Anne R Kopf-Sill (4 out of 97 patents)


Core Competencies:
Immunoassays
Peptide Detection
Signal Amplification
Analytical Rotors
Lateral Flow
Biological Fluids
Fluid Transport
Centrifugal Separation
Dried Chemical Compositions
Error Checking
Ultrasonic Welding
Reagent Compositions

60 patents:

1. 10921321 - Peptides and methods for the detection of Lyme disease antibodies (2021-02-16),
2. 10919039 - Devices with modified conduits (2021-02-16),
3. 10620196 - Assays for detecting analytes in samples and kits and compositions related thereto (2020-04-14),
4. 10488409 - Signal amplification in plasmonic specific-binding partner assays (2019-11-26),
5. 10444231 - Peptides, devices, and methods for the detection ofantibodies (2019-10-15),
6. 10429383 - Signal amplification in solution-based plasmonic specific-binding partner assays (2019-10-01),
7. 10371701 - Rotors for immunoassays (2019-08-06),
8. 10330687 - Peptides, devices, and methods for the detection of anaplasma antibodies (2019-06-25),
9. 10281465 - Signal amplification in lateral flow and related immunoassays (2019-05-07),
10. 10073095 - Peptides and methods for the detection of lyme disease antibodies (2018-09-11),
11. 9921218 - Signal amplification in lateral flow and related immunoassays (2018-03-20),
12. 9851352 - [object Object] (2017-12-26),
13. 9835622 - Signal amplification in solution-based plasmonic specific-binding partner assays (2017-12-05),
14. 9816987 - Rotors for immunoassays (2017-11-14),
15. 9766238 - Peptides and methods for the detection of lyme disease antibodies (2017-09-19),
Company Overview
Abaxis, Inc. is a technology-driven company based in Union City, California, specializing in immunoassay technology. The organization focuses on developing innovative solutions for the detection of peptides and other biomolecules in biological fluids. Its core competencies include signal amplification, analytical rotors, and lateral flow systems, which enhance the accuracy and efficiency of diagnostic testing. Abaxis is committed to advancing healthcare through its expertise in fluid transport and centrifugal separation technologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Abaxis, Inc. USPTO Patent Assignee Logo
60 Patents

#2 in Union City, CA

#1,401 in California

#5,991 in US

#12,077 in the World

Union City, CA (US)
Union City, CA, United States of America

Abaxis, Inc.

Forward Citations = 1,897

39 inventors:

goldMedal Rajesh K Mehra (32 out of 46 patents)

silverMedal Kenneth P Aron (32 out of 52 patents)

bronzeMedal Dennis M Bleile (22 out of 27 patents)

4.  Jeremy D Walker (17 out of 22 patents)

5.  Cristina R Cuesico (15 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abaxis, Inc.. Retrieved from https://idiyas.com/company/abaxis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…